Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Brinzolamide Fixed Combination in Glaucoma/OHT
NCT02140060Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2014
- Primary completion
- Nov 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 2 trial of travoprost, brinzolamide in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jun 2014; status: completed.
02
Drugs
travoprostbrinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02140060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140060.